Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
LabCorp Lands a Global CRO
In late July, Laboratory Corp. of America Holdings (NYSE: LH) announced the 6th CRO deal to surpass the $1 billion mark this year. The $1.2 billion deal for Chiltern is its third announced transaction this year, having acquired Mount Sinai’s Clinical Outreach Laboratories (January) and Pathology Associates Medical Laboratories, LLC (February). Despite activity in the Laboratory, MRI & Dialysis sector, LabCorp was on the hunt for a CRO target all year, but with little luck. Back in February, it was rumored that LabCorp was looking to buy Pharmaceutical Product Development, LLC for $8 billion. PPD ended up going to Hellman & Friedman LLC, a long time... Read More »Health Care M&A Weekly Deals, The Week Ending July 28, 2017
Health Care M&A Weekly Deals, The Week Ending July 28,... Read More »Follow the Funding, July 2017
This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors. TargetInvestorsAmountDate Theranics Bio-ElectronicsLightspeed Venture Partners, LionBird and Corundum Open Innovation$6 million, Series AJuly 3, 2017 Diasome Pharmaceuticals, Inc.Medicxi Ventures, JDRF T1D Fund, Black Beret Life Sciences, LLC and McDonald Partners, LLC$30 millionJuly 5, 2017 Omni Eye ServicesNew MainStream CapitalUndisclosedJuly 6, 2017 GenooxInimiti Capital Partners and Glilot Capital$6 millionJuly 11, 2017 Allurion TechnologiesRomulus Capital, with Cogepa Investments and IDO Investments$27 million, Series... Read More »
Evergreen Health’s For-Profit Bid Withers
The Managed Care sector went two steps forward, then one step back in July. Two deals were announced in the span of two days, and as the month neared a close, another deal was terminated, leaving this year’s total at a sluggish 10 deals. Back in May 2017, we reported on Evergreen Health’s journey to become a for-profit, provider-sponsored plan in Maryland. The company was birthed as an insurance co-op under the Affordable Care Act and has struggled to survive since. In October 2016, Evergreen put itself up for sale as a result of unprofitability and growing indebtedness to the Center for Medicare and Medicaid Services. Then, on May 2, a group of investors agreed to buy the company, which... Read More »
Long-Term Care Deals Hold Steady in Q2:17
Merger and acquisition activity stayed virtually even in the second quarter, down 1% from the previous quarter, to 75 transactions. The quarter’s deal volume makes up 24% of the 315 deals announced within the past 12 months. Q2:17’s deal volume is 17% lower than the same period a year earlier. Source: HealthCareMandA.com, July 2017 Based on revealed prices, approximately $9.7 billion was committed to finance second quarter deals, an increase of 574% compared with the previous quarter and 299% higher than the same period in 2016. The second quarter accounted for 47% of the $20.6 billion spent in the last 12 months. Forty-four of the 75 deals disclosed prices, and two were more than $1... Read More »
WebMD Goes Private in $3.6 Billion Deal
A portfolio company of KKR (NYSE: KKR) just announced the 99th eHealth deal of 2017, and the second largest eHealth deal in our M&A database dating back to 1993. On July 24, 2017, KKR portfolio company Internet Brands, an online media and software services organization, announced the acquisition of WebMD Health Corp. (NASDAQ: WBMD). The company provides health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms and health-focused publications. The deal comes five months after New York-based WebMD said it would explore strategic options following a slowdown in... Read More »
Home Health and Hospice Sector Hit by Headwinds
The Home Health & Hospice sector has experienced a few headwinds in 2017. Besides the ongoing labor shortage, reimbursement levels would be severely impacted by the passage of the Senate Republicans’ Better Care Reconciliation Act, which curtails federal spending on Medicaid beginning in 2020. Little surprise, then, that deal volume faded in the second quarter, to nine transactions. Deal volume in Q2:17 fell to 10 transactions, which represent 18% of the 55 deals announced in the past 12 months. Compared with the same period a year earlier, deal volume was down 31%. Source: HealthCareMandA.com, July 2017 None of the deals announced disclosed financial terms. Dollars Spent on Home... Read More »Health Care M&A Weekly Deals, The Week Ending July 21, 2017
Health Care M&A Weekly Deals, The Week Ending July 21,... Read More »Behavioral Health Deals Tumble in Q2:17
Deal activity in the Behavioral Health Care sector plummeted in Q2:17, down 50% compared with the previous quarter, and down 53% compared with the same quarter a year earlier. The quarter’s total of eight deals represents 21% of the 39 transactions announced in the past 12 months. In fact, those two quarters—Q1:17 and Q2:16—had the highest number of deals in the preceding 12 months, so the news is not quite as dire as it appears. The second quarter’s deal volume is equal to that of Q4:16 and Q3:16. The passage of the 21st Century Cures Act in December 2016 brought additional focus and spending on substance abuse programs, particularly for opioid addiction, and mental health issues.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
